Saatja: Tadeusz Hawrot, EFNA <
[email protected]>
Saadetud: 13.12.2018 16:05
Adressaat: <
[email protected]>
Teema: EP event invitation; neurological disorders leading cause of
disability and the 2nd leading cause of death in Europe
INVITATION
The European Academy of Neurology is conducting a research project
assessing neurological care in Europe as well as re-examining the burden
on neurological disorders, based on the Global Burden of Disease study.
The data will reveal that neurological disorders are the leading cause of
disability and the second leading cause of death in Europe.
The project will be discussed at the meeting in the European Parliament
on 23rd January and we are delighted to invite you to join its carefully
selected participants.
More details can be found in the attached invitation.
You are invited to register until 10th January by filling in this form:
With kind regards,
Tadeusz HawrotSenior Advocacy CoordinatorEUROPEAN FEDERATION OF
NEUROLOGICAL ASSOCIATIONSemail: tel: (+351) 920 39 19 29 | |
LIFTING THE BURDEN OF NEUROLOGICAL DISORDERS IN EUROPE
Wednesday, January 23rd 2019, European Parliament, Brussels
Opening Addresses
MEP Karin Kadenbach & Franz Fazekas, President, European Academy of Neurology
Presentation 1: The Global Burden of Neurology: Does resource allocation match the
burden?
Prof. Guenther Deuschl, Past President, European Academy of Neurology
Prof. Ettore Beghi, International League Against Epilepsy
Highlighting the high placing of neurological disorders in the latest Global Burden of Disease
Report – and illustrating the disparity between burden and resources allocation in Europe
Presentation 2: Neurology Treatment and Care in Europe: Where are the gaps?
Prof. Franz Fazekas, President, European Academy of Neurology
Using EAN’s current work in highlighting the gaps across Europe in treatment and care for
patients living with neurological disorders, as a case-study to show what needs to be done
and how
Panel Discussion: Putting Neurology on the Global Agenda
Moderator: John Bowis
This discussion will provide advice on how stakeholders can work together to advocate for
increased priority for neurological disorders at the Global, EU and Member State level.
Invited panelists include:
1. WHO - TBC
2. European Commission, DG Research, TBC
2. European Brain Council, Frédéric Destrebecq, Executive Director
3. BioMed Alliance – Prof. A. Pries, President
4. Scientific Panel for Health – Prof. K. Sipido
Keynote Address: European Commission, DG SANTE [TBC]
Close
MEP Karin Kadenbach & Joke Jaarsma, President, European Federation of Neurological
Associations
Invitation to a joint EAN – EFNA event “Lifting the burden of neurological diseases in Europe”
The European Academy of Neurology [EAN], together with the European Federation of Neurological
Associations [EFNA], kindly invite you to an informative event in the European Parliament in Brussels
on 23 January 2019, 10h00-12h00.
The socio-economic burden of neurological diseases – such as Alzheimer’s, stroke and Parkinson
Disease – on European societies is very heavy. An ever-ageing European population contributes to
the increase of these diseases, but does not allow us to overlook the incidence of these disorders in
the young – meaning that more than 1 in 3 people will have a brain disorder in their lifetime.
The EAN, representing all national neurological societies across our continent, has started a research
project – Neuro-care – which aims to better understand the differences in neurological care provision
in Europe; providing feedback on country-specific needs and recommendations on how countries can
deal with these. The obtained data will become available to EU governments for better and more
rational planning of national health budgets. With this in mind, we would like to highlight the
disparities in the availability of neurological care in the EU Member States and what can be done to
improve the situation. The Neuro-care project is also re-examining the burden on neurological
disorders, based on the Global Burden of Disease study and corresponding data recently published in
the Lancet Neurology.
The neurological community has been waiting for these estimates for years as until now no
comprehensive unified data were available. Now, in this most extensive study ever conducted on
neurological disorders in Europe, we will have the best available estimates of incidence, prevalence,
mortality and disability from the major non-communicable neurological disorders in EU countries.
The data will reveal that neurological disorders are the leading cause of disability and the second
leading cause of death in Europe.
Such estimates are crucial for evidence-based health care planning, resource allocation and priority
setting for research. They clearly demonstrate that brain health is becoming the greatest challenge for
Europe in the 21st century. We hope that they will serve as a wakeup call for health care systems and
research funding agencies, as the data show that neurology and neurosciences must be on the top
priority lists.
We hope you can positively consider our invitation and be with us on the day to complete the
discussion with your expertise on how this enormous challenge can be tackled together.
Looking forward to hearing from you, we remain,
Sincerely yours,
Prof. Franz Fazekas Mrs. Joke Jaarsma
EAN, President EFNA, President